Data from Delineation of a Cellular Hierarchy in Lung Cancer Reveals an Oncofetal Antigen Expressed on Tumor-Initiating Cells
Marc Damelin(Pfizer (United States)), Bin‐Bing S. Zhou(New Frontier), Carmen Behrens, Robert T. Abraham(Sanford Burnham Prebys Medical Discovery Institute), Jonathon Golas(Pfizer (United States)), Erwin R. Boghaert(AbbVie (United States)), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), John F. DiJoseph, Kenneth G. Geles, Ping Yuan(Anhui Medical University), Michelle Baxter, Sung Choe(Agios Pharmaceuticals (United States)), Kimberly Marquette, Lioudmila Tchistiakova(Pfizer (United States)), Maureen Dougher, Veronica Diesl(Pfizer (United States)), Latha Sridharan, Douglas Armellino, Kiran Khandke, Deborah G. Evans(University of New Mexico), Shuguang Huang(Pfizer (United States)), Arthur Kunz, Maximillian T. Follettie(Pfizer (United States)), Maha Karnoub, Philip R. Hamann, Janet Gruzas
Cited by 0
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
Guidelines for the use and interpretation of assays for monitoring autophagy
|Autophagy|2012|4.1k
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k